After trading in far smaller daily volume over the past few months, yesterday Marina Biotech, Inc. (OTCMKTS:MRNA) suddenly sprang into action with over 570 thousand shares changing hands. The stock put on 11% and...
Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP) acts truly concerned about its future, and luckily, in the past days offered up important corporate updates. At the same time, the stock price still seeks direction. On Monday, the...
The stock of Marina Biotech, Inc. (OTCMKTS:MRNA) was revived recently as a promising pharmaceutical bet for investors after it was announced that they have acquired $6 million in funding at the cost of issuance...
We are still waiting for Tengion, Inc. (OTCMKTS:TNGN) make a more discernible move in its price, as for now what we have are daily spikes that hardly form a trend in the early months...
Amerilithium, Corp. (OTCMKTS:AMEL) remained hidden for a while, quietly deflating in price on low volumes. But the past month awakened trading, leading to Monday’s record volumes. AMEL rose by more than 270% to stand...
Bioelectronics Corp. (OTCMKTS:BIEL) is fighting to keep the rapid gains it made a few days back, after positive FDA news and a boost from a promotional email. After a threatening correction, BIEL added more...
Marina Biotech, Inc. (OTCMKTS:MRNA) made a remarkable run in the past three days, as it sent out updates on its already patent-protected therapy. On Tuesday, MRNA grew by more than 20% to $1.708, on...
Marina Biotech, Inc. (OTCMKTS:MRNA) is a stranger in a strange land right now- a biopharmaceutical company that sticks to its line of research, and has no chance of jumping over to become a medical...